The global Adults Genetic Disease Diagnosis market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

Adult genetic disease diagnosis involves testing to identify genetic disorders that manifest later in life. This can include conditions like Huntington's disease, certain types of cancer, or hereditary heart diseases. Methods often include blood tests, genetic sequencing, and family history assessments, enabling healthcare providers to offer personalized treatment and management plans.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Adults Genetic Disease Diagnosis leading manufacturers including Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Adults Genetic Disease Diagnosis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Adults Genetic Disease Diagnosis Market Report

Report Metric	Details
Report Name	Adults Genetic Disease Diagnosis Market
Segment by Type	Prenatal Diagnosis Screening for Single Gene Genetic Disease Preimplantation Genetic Testing Others
Segment by Application	Hospital Medical Laboratory Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Adults Genetic Disease Diagnosis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Adults Genetic Disease Diagnosis Market report?

Ans: The main players in the Adults Genetic Disease Diagnosis Market are Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology

What are the Application segmentation covered in the Adults Genetic Disease Diagnosis Market report?

Ans: The Applications covered in the Adults Genetic Disease Diagnosis Market report are Hospital, Medical Laboratory, Others

What are the Type segmentation covered in the Adults Genetic Disease Diagnosis Market report?

Ans: The Types covered in the Adults Genetic Disease Diagnosis Market report are Prenatal Diagnosis, Screening for Single Gene Genetic Disease, Preimplantation Genetic Testing, Others

1 Study Coverage

1.1 Introduction to Adults Genetic Disease Diagnosis: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Adults Genetic Disease Diagnosis Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Prenatal Diagnosis

1.2.3 Screening for Single Gene Genetic Disease

1.2.4 Preimplantation Genetic Testing

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Adults Genetic Disease Diagnosis Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Medical Laboratory

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Adults Genetic Disease Diagnosis Revenue Estimates and Forecasts 2020-2031

2.2 Global Adults Genetic Disease Diagnosis Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Adults Genetic Disease Diagnosis Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Adults Genetic Disease Diagnosis Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Prenatal Diagnosis Market Size by Players

3.3.2 Screening for Single Gene Genetic Disease Market Size by Players

3.3.3 Preimplantation Genetic Testing Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global Adults Genetic Disease Diagnosis Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Adults Genetic Disease Diagnosis Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Adults Genetic Disease Diagnosis Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)

6.4 North America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Adults Genetic Disease Diagnosis Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)

7.4 Europe Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Adults Genetic Disease Diagnosis Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)

8.4 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Adults Genetic Disease Diagnosis Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)

9.4 Central and South America Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Adults Genetic Disease Diagnosis Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Type (2020-2031)

10.4 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Adults Genetic Disease Diagnosis Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abbott

11.1.1 Abbott Corporation Information

11.1.2 Abbott Business Overview

11.1.3 Abbott Adults Genetic Disease Diagnosis Product Features and Attributes

11.1.4 Abbott Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.1.5 Abbott Adults Genetic Disease Diagnosis Revenue by Product in 2024

11.1.6 Abbott Adults Genetic Disease Diagnosis Revenue by Application in 2024

11.1.7 Abbott Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024

11.1.8 Abbott Adults Genetic Disease Diagnosis SWOT Analysis

11.1.9 Abbott Recent Developments

11.2 PerkinElmer

11.2.1 PerkinElmer Corporation Information

11.2.2 PerkinElmer Business Overview

11.2.3 PerkinElmer Adults Genetic Disease Diagnosis Product Features and Attributes

11.2.4 PerkinElmer Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.2.5 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Product in 2024

11.2.6 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Application in 2024

11.2.7 PerkinElmer Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024

11.2.8 PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis

11.2.9 PerkinElmer Recent Developments

11.3 Roche Diagnostics

11.3.1 Roche Diagnostics Corporation Information

11.3.2 Roche Diagnostics Business Overview

11.3.3 Roche Diagnostics Adults Genetic Disease Diagnosis Product Features and Attributes

11.3.4 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.3.5 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Product in 2024

11.3.6 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Application in 2024

11.3.7 Roche Diagnostics Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024

11.3.8 Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis

11.3.9 Roche Diagnostics Recent Developments

11.4 Bio Rad

11.4.1 Bio Rad Corporation Information

11.4.2 Bio Rad Business Overview

11.4.3 Bio Rad Adults Genetic Disease Diagnosis Product Features and Attributes

11.4.4 Bio Rad Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.4.5 Bio Rad Adults Genetic Disease Diagnosis Revenue by Product in 2024

11.4.6 Bio Rad Adults Genetic Disease Diagnosis Revenue by Application in 2024

11.4.7 Bio Rad Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024

11.4.8 Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis

11.4.9 Bio Rad Recent Developments

11.5 Thermo Fisher Scientific

11.5.1 Thermo Fisher Scientific Corporation Information

11.5.2 Thermo Fisher Scientific Business Overview

11.5.3 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Product Features and Attributes

11.5.4 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.5.5 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Product in 2024

11.5.6 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Application in 2024

11.5.7 Thermo Fisher Scientific Adults Genetic Disease Diagnosis Revenue by Geographic Area in 2024

11.5.8 Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis

11.5.9 Thermo Fisher Scientific Recent Developments

11.6 BGI Group

11.6.1 BGI Group Corporation Information

11.6.2 BGI Group Business Overview

11.6.3 BGI Group Adults Genetic Disease Diagnosis Product Features and Attributes

11.6.4 BGI Group Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.6.5 BGI Group Recent Developments

11.7 Berry Genomics

11.7.1 Berry Genomics Corporation Information

11.7.2 Berry Genomics Business Overview

11.7.3 Berry Genomics Adults Genetic Disease Diagnosis Product Features and Attributes

11.7.4 Berry Genomics Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.7.5 Berry Genomics Recent Developments

11.8 Da An Gene Co., Ltd.

11.8.1 Da An Gene Co., Ltd. Corporation Information

11.8.2 Da An Gene Co., Ltd. Business Overview

11.8.3 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Product Features and Attributes

11.8.4 Da An Gene Co., Ltd. Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.8.5 Da An Gene Co., Ltd. Recent Developments

11.9 Illumina

11.9.1 Illumina Corporation Information

11.9.2 Illumina Business Overview

11.9.3 Illumina Adults Genetic Disease Diagnosis Product Features and Attributes

11.9.4 Illumina Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.9.5 Illumina Recent Developments

11.10 CapitalBio Technology

11.10.1 CapitalBio Technology Corporation Information

11.10.2 CapitalBio Technology Business Overview

11.10.3 CapitalBio Technology Adults Genetic Disease Diagnosis Product Features and Attributes

11.10.4 CapitalBio Technology Adults Genetic Disease Diagnosis Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

12 Adults Genetic Disease DiagnosisIndustry Chain Analysis

12.1 Adults Genetic Disease Diagnosis Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Adults Genetic Disease Diagnosis Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Adults Genetic Disease Diagnosis Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

CapitalBio Technology

List of Tables

Table 1. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Adults Genetic Disease Diagnosis Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Adults Genetic Disease Diagnosis Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Adults Genetic Disease Diagnosis Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Adults Genetic Disease Diagnosis Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Adults Genetic Disease Diagnosis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adults Genetic Disease Diagnosis as of 2024)

Table 11. Global Adults Genetic Disease Diagnosis Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Adults Genetic Disease Diagnosis Companies Headquarters

Table 13. Global Adults Genetic Disease Diagnosis Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Adults Genetic Disease Diagnosis Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Adults Genetic Disease Diagnosis Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Adults Genetic Disease Diagnosis Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Adults Genetic Disease Diagnosis Revenue by Application (2026-2031) & (US$ Million)

Table 21. Adults Genetic Disease Diagnosis High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers

Table 25. North America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers

Table 27. Europe Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Adults Genetic Disease Diagnosis Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges

Table 31. Central and South America Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Adults Genetic Disease Diagnosis Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Adults Genetic Disease Diagnosis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Abbott Corporation Information

Table 35. Abbott Description and Major Businesses

Table 36. Abbott Product Features and Attributes

Table 37. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Abbott Revenue Proportion by Product in 2024

Table 39. Abbott Revenue Proportion by Application in 2024

Table 40. Abbott Revenue Proportion by Geographic Area in 2024

Table 41. Abbott Adults Genetic Disease Diagnosis SWOT Analysis

Table 42. Abbott Recent Developments

Table 43. PerkinElmer Corporation Information

Table 44. PerkinElmer Description and Major Businesses

Table 45. PerkinElmer Product Features and Attributes

Table 46. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. PerkinElmer Revenue Proportion by Product in 2024

Table 48. PerkinElmer Revenue Proportion by Application in 2024

Table 49. PerkinElmer Revenue Proportion by Geographic Area in 2024

Table 50. PerkinElmer Adults Genetic Disease Diagnosis SWOT Analysis

Table 51. PerkinElmer Recent Developments

Table 52. Roche Diagnostics Corporation Information

Table 53. Roche Diagnostics Description and Major Businesses

Table 54. Roche Diagnostics Product Features and Attributes

Table 55. Roche Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Roche Diagnostics Revenue Proportion by Product in 2024

Table 57. Roche Diagnostics Revenue Proportion by Application in 2024

Table 58. Roche Diagnostics Revenue Proportion by Geographic Area in 2024

Table 59. Roche Diagnostics Adults Genetic Disease Diagnosis SWOT Analysis

Table 60. Roche Diagnostics Recent Developments

Table 61. Bio Rad Corporation Information

Table 62. Bio Rad Description and Major Businesses

Table 63. Bio Rad Product Features and Attributes

Table 64. Bio Rad Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Bio Rad Revenue Proportion by Product in 2024

Table 66. Bio Rad Revenue Proportion by Application in 2024

Table 67. Bio Rad Revenue Proportion by Geographic Area in 2024

Table 68. Bio Rad Adults Genetic Disease Diagnosis SWOT Analysis

Table 69. Bio Rad Recent Developments

Table 70. Thermo Fisher Scientific Corporation Information

Table 71. Thermo Fisher Scientific Description and Major Businesses

Table 72. Thermo Fisher Scientific Product Features and Attributes

Table 73. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Thermo Fisher Scientific Revenue Proportion by Product in 2024

Table 75. Thermo Fisher Scientific Revenue Proportion by Application in 2024

Table 76. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024

Table 77. Thermo Fisher Scientific Adults Genetic Disease Diagnosis SWOT Analysis

Table 78. Thermo Fisher Scientific Recent Developments

Table 79. BGI Group Corporation Information

Table 80. BGI Group Description and Major Businesses

Table 81. BGI Group Product Features and Attributes

Table 82. BGI Group Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. BGI Group Recent Developments

Table 84. Berry Genomics Corporation Information

Table 85. Berry Genomics Description and Major Businesses

Table 86. Berry Genomics Product Features and Attributes

Table 87. Berry Genomics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Berry Genomics Recent Developments

Table 89. Da An Gene Co., Ltd. Corporation Information

Table 90. Da An Gene Co., Ltd. Description and Major Businesses

Table 91. Da An Gene Co., Ltd. Product Features and Attributes

Table 92. Da An Gene Co., Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Da An Gene Co., Ltd. Recent Developments

Table 94. Illumina Corporation Information

Table 95. Illumina Description and Major Businesses

Table 96. Illumina Product Features and Attributes

Table 97. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Illumina Recent Developments

Table 99. CapitalBio Technology Corporation Information

Table 100. CapitalBio Technology Description and Major Businesses

Table 101. CapitalBio Technology Product Features and Attributes

Table 102. CapitalBio Technology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. CapitalBio Technology Recent Developments

Table 104. Raw Materials Key Suppliers

Table 105. Distributors List

Table 106. Market Trends and Market Evolution

Table 107. Market Drivers and Opportunities

Table 108. Market Challenges, Risks, and Restraints

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Adults Genetic Disease Diagnosis Product Picture

Figure 2. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Prenatal Diagnosis Product Picture

Figure 4. Screening for Single Gene Genetic Disease Product Picture

Figure 5. Preimplantation Genetic Testing Product Picture

Figure 6. Others Product Picture

Figure 7. Global Adults Genetic Disease Diagnosis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Hospital

Figure 9. Medical Laboratory

Figure 10. Others

Figure 11. Adults Genetic Disease Diagnosis Report Years Considered

Figure 12. Global Adults Genetic Disease Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 14. Global Adults Genetic Disease Diagnosis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 15. Global Adults Genetic Disease Diagnosis Revenue Market Share by Region (2020-2031)

Figure 16. Global Adults Genetic Disease Diagnosis Revenue Market Share Ranking (2024)

Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 18. Prenatal Diagnosis Revenue Market Share by Player in 2024

Figure 19. Screening for Single Gene Genetic Disease Revenue Market Share by Player in 2024

Figure 20. Preimplantation Genetic Testing Revenue Market Share by Player in 2024

Figure 21. Others Revenue Market Share by Player in 2024

Figure 22. Global Adults Genetic Disease Diagnosis Revenue Market Share by Type (2020-2031)

Figure 23. Global Adults Genetic Disease Diagnosis Revenue Market Share by Application (2020-2031)

Figure 24. North America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)

Figure 25. North America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024

Figure 26. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020 - 2031)

Figure 27. North America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)

Figure 28. US Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 29. Canada Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 30. Mexico Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 31. Europe Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)

Figure 32. Europe Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024

Figure 33. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)

Figure 34. Europe Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)

Figure 35. Germany Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 36. France Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 37. U.K. Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 38. Italy Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 39. Russia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Top 8 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024

Figure 42. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)

Figure 43. Asia-Pacific Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)

Figure 44. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 45. Japan Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 46. South Korea Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 47. Australia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 48. India Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 49. Indonesia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 50. Vietnam Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 51. Malaysia Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 52. Philippines Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 53. Singapore Adults Genetic Disease Diagnosis Revenue (2020-2031) & (US$ Million)

Figure 54. Central and South America Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)

Figure 55. Central and South America Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024

Figure 56. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)

Figure 57. Central and South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)

Figure 58. Brazil Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 59. Argentina Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 60. Middle East and Africa Adults Genetic Disease Diagnosis Revenue YoY (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Top 5 Players Adults Genetic Disease Diagnosis Revenue (US$ Million) in 2024

Figure 62. South America Adults Genetic Disease Diagnosis Revenue (US$ Million) by Type (2020-2031)

Figure 63. Middle East and Africa Adults Genetic Disease Diagnosis Revenue (US$ Million) by Application (2020-2031)

Figure 64. GCC Countries Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 65. Israel Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 66. Egypt Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 67. South Africa Adults Genetic Disease Diagnosis Revenue (2020-2025) & (US$ Million)

Figure 68. Adults Genetic Disease Diagnosis Industry Chain Mapping

Figure 69. Channels of Distribution (Direct Vs Distribution)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33V17945

Thu Oct 23 00:00:00 UTC 2025

Add to Cart

Global Moxibustion Bed Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-38K17791

Thu Oct 23 00:00:00 UTC 2025

Add to Cart

Global Veterinary Lyme Disease Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-17K18234

Thu Oct 23 00:00:00 UTC 2025

Add to Cart

Global Allergy Apps Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-26A17172

Thu Oct 23 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Adults Genetic Disease Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-31T19874

Global Adults Genetic Disease Diagnosis Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Adults Genetic Disease Diagnosis Market

Report Includes:

Scope of Adults Genetic Disease Diagnosis Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Adults Genetic Disease Diagnosis Market report?

What are the Application segmentation covered in the Adults Genetic Disease Diagnosis Market report?

What are the Type segmentation covered in the Adults Genetic Disease Diagnosis Market report?

FEATURED COMPANIES

RELATED REPORTS